Literature DB >> 11103806

The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damage.

D Sampath1, W Plunkett.   

Abstract

Activation of the c-Jun NH2-terminal kinase type 1 (JNK1) signaling pathway is often associated with apoptosis. In this report, we elucidated the role of this kinase in the programmed cell death induced by the nucleoside analogue 9-beta-D-arabinosyl-2-fluoroadenine (F-ara-A). Treatment of ML-1 cells with 3 or 10 microM F-ara-A specifically killed cells in the S-phase of the population. Incorporation of F-ara-ATP, the nucleoside triphosphate of F-ara-A, into DNA resulted in the activation of JNK1 in a time- and dose-dependent fashion. Activation of JNK1 temporally preceded DNA fragmentation. When incorporation of F-ara-A into DNA was blocked by pretreatment of the cells with aphidicolin to inhibit DNA synthesis, neither JNK1 signaling nor apoptosis was evident. Furthermore, inhibition of JNK1 by treatment of the cells with forskolin or by pretreatment with an antisense oligonucleotide directed against JNK1 mRNA resulted in a decrease in F-ara-A-induced apoptosis. Finally, the JNK1 signaling pathway appeared to be upstream to that of the effector caspases in nucleoside analogue-induced apoptosis. Thus, our data strongly suggest that JNK1 is involved in transduction of F-ara-A-induced distress signals into an apoptotic response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11103806

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Enhancing CHK1 inhibitor lethality in glioblastoma.

Authors:  Yong Tang; Yun Dai; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2012-04-01       Impact factor: 4.742

2.  Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

Authors:  Deepa Sampath; Jorge Cortes; Zeev Estrov; Min Du; Zheng Shi; Michael Andreeff; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

3.  Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation.

Authors:  Stephanie Oliere; Meztli Arguello; Thibault Mesplede; Vanessa Tumilasci; Peyman Nakhaei; David Stojdl; Nahum Sonenberg; John Bell; John Hiscott
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

4.  Targeting DNA repair with aphidicolin sensitizes primary chronic lymphocytic leukemia cells to purine analogs.

Authors:  Eliza Starczewska; Maxime Beyaert; Lucienne Michaux; Marie-Christiane Vekemans; Pascale Saussoy; Vanesa Bol; Ainhoa Arana Echarri; Caroline Smal; Eric Van Den Neste; Françoise Bontemps
Journal:  Oncotarget       Date:  2016-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.